|
|
Volumn 334, Issue 7586, 2007, Pages 171-
|
|
Lilly investigated in US over the marketing of olanzapine.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
OLANZAPINE;
ARTICLE;
DRUG INDUSTRY;
HUMAN;
LEGAL ASPECT;
MARKETING;
SCHIZOPHRENIA;
UNITED STATES;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
DRUG INDUSTRY;
HUMANS;
MARKETING;
SCHIZOPHRENIA;
UNITED STATES;
|
|
EID: 33847118126
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.39105.427731.DB Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
